Zimmer Biomet Holdings, Inc. (ZBH)
|Net Income (ttm)||916.20M|
|Ex-Dividend Date||Sep 29, 2021|
|Day's Range||149.17 - 151.73|
|52-Week Range||129.45 - 180.10|
|Price Target||188.62 (+24.6%)|
|Est. Earnings Date||Nov 5, 2021|
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as pr... [Read more...]
Financial PerformanceFinancial Statements
According to 30 analysts, the average rating for Zimmer Biomet stock is "Buy." The 12-month stock price forecast is 188.62, which is an increase of 24.63% from the latest price.
Zimmer (ZBH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zimmer Biomet Announces Key Additions to "NewCo" Leadership Team; Transaction to Form New Independent, Publicly Trade...
WARSAW, Ind., Sept. 14, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key appointments to the "NewCo" leadership team, includ...
Zimmer Biomet's (ZBH) leveraged capital structure is an added concern.
WARSAW, Ind. , Sept. 3, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of...
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Zimmer Biomet (ZBH) presented four data presentations backing the mymobility with Apple Watch platform at the AAOS 2021 Annual Meeting.
Zimmer Biomet Announces New Data Supporting Clinical Benefits of mymobility® with Apple Watch® at AAOS 2021
WARSAW, Ind., Aug. 31, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced four data presentations on the clinical value of mymobil...
WARSAW, Ind., Aug. 31, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chairman, President and CEO Bryan Hanson and Execut...
Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World's Fi...
WARSAW, Ind. and VANCOUVER, BC, Aug. 30, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Canary Medical, a medical data company, today anno...
The recent FDA go-ahead for Zimmer Biomet's (ZBH) ROSA Hip System will aid surgeons perform robotically-assisted direct anterior total hip replacement surgery.
Zimmer Biomet Holdings Inc (NYSE: ZBH) has received FDA 510(k) clearance for its Rosa Hip system for robotically-assisted surgery. The system is designed for direct anterior total hip replacement.
Zimmer Biomet Receives FDA Clearance for ROSA® Hip System for Robotically-Assisted Direct Anterior Total Hip Arthropl...
WARSAW, Ind., Aug. 18, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
Zimmer Biomet to Unveil New Clinical Data and Portfolio of Innovative Technologies at AAOS 2021 Annual Meeting
WARSAW, Ind., Aug. 17, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced six data presentations at the American Academy of Orthop...
Zimmer Biomet (ZBH) sees slower recovery amid the emergence of a new strain of coronavirus in a number of markets, including Japan.
The stock price of Zimmer Biomet Holdings, a medical devices company, reached its all-time high of $178 in April this year, but it has since seen lower levels. A recent sell-off in the stock has led to ...
Zimmer Biomet Holdings Inc (NYSE: ZBH) posted Q2 adjusted EPS of $1.90, ahead of the consensus of $1.87 and higher than $0.05 posted a year ago. It reported a profit of $142.5 million, upping its bottom...
Zimmer Biomet (ZBH) sales improve across all its operating segments and geographies on recovery from the pandemic in the months of the second quarter.
Zimmer (ZBH) delivered earnings and revenue surprises of 3.26% and 2.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Zimmer Biomet Holdings (NYSE:ZBH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 3700.00% over the past year to $1.90, which beat the esti...
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zimmer Biomet's (ZBH) S.E.T. is expected to have performed better than expected on the back of the company's focus on sports and extremities, especially upper extremities, trauma and CMFT.
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Which stocks you should own if the economy slows due to delta
Cliff Hodge, Chief Investment Officer at Cornerstone Wealth and Mark Avallone, President of Potomac Wealth Advisors, join Kelly Evans on The Exchange to discuss their top stock picks to hold onto if the...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.